Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Resignation of Directors
On December 19, 2022, Jay Jones, a member of the Board of Directors (the
"Board") of SurgePays, Inc. (the "Company"), notified the Company of his
resignation as Director, with such resignation to become effective immediately.
Such resignation is not the result of any disagreement with the Company on any
matter relating to the Company's operations, policies or practices. In
connection with Mr. Jones' resignation, the Board entered into a Consulting
Agreement with Mr. Jones dated December 19, 2022 (the "Consulting Agreement").
Pursuant to such Consulting Agreement, the Company agrees to engage Mr. Jones as
a consultant ("the Consultant") to provide advice to the Board and senior
management of the Company regarding general business matters. The Consultant has
industry and Company knowledge that is valuable to the Company and its ongoing
business ventures. The term of the Consultant Agreement is for a period of
twelve (12) months, in which the Consultant's duties include reporting to the
Board and senior management of the Company and advising them in respect to
business matters. Following an annual or special meeting of the Company's
stockholders at which stockholders approve the SurgePays, Inc. 2022 Omnibus
Securities and Incentive Plan (the "Incentive Plan"), the Consultant's
compensation will consist of stock options with a value of $5,000 on the first
trading day of each calendar month during the term. Each month's options will
have an exercise price equal to the fair market value of the Company's common
stock on the last trading day of the previous calendar month. All options
granted on the first trading day of each calendar month shall vest immediately,
and the options will be issued quarterly in accordance with the Incentive Plan.
The Consultant is considered an independent contractor and will be reimbursed
for (i) all reasonable out-of-pocket expenses and (ii) any costs associated with
filing required to be made by him or any of the entities managed or controlled
by the Consultant to report beneficial ownership or the acquisition or
disposition of securities by the Company.
The foregoing description of the Consulting Agreement does not purport to be
complete and is qualified in its entirety by the full text of the Consulting
Agreement, a form of which is filed as Exhibit 10.1 and is incorporated herein
by reference.
On December 19, 2022, David May notified the Company of his resignation,
effectively immediately, as a member of the Board's Audit Committee,
Compensation Committee, and the Nominating and Corporate Governance Committee.
Such resignation from the Board committees is not the result of any disagreement
with the Company on any matter relating to the Company's operations, policies or
practices. Mr. May remains a member of the Board.
Appointment of Directors
On December 19, 2022, the Company appointed Laurie Weisberg as a member of the
Board and to serve as a member of the Audit Committee, Compensation Committee,
and the Nominating and Corporate Governance Committee (the "Weisberg
Appointment"). Ms. Weisberg was appointed to serve as chair of the Compensation
Committee.
On December 19, 2022, the Company appointed Richard Schurfeld as a member of the
Board and to serve as a member of Audit Committee, Compensation Committee, and
the Nominating and Corporate Governance Committee. Mr. Schurfeld was appointed
to serve as chair of the Nominating and Corporate Governance Committee (the
"Schurfeld Appointment").
Appointment of Laurie Weisberg
The Company and Ms. Weisberg entered in a Director Agreement, dated December 19,
2022 (the "Weisberg Director Agreement"). Pursuant to the Weisberg Director
Agreement, Ms. Weisberg shall make reasonable business efforts to attend all
Board meetings and fulfill her other responsibilities as well as use her best
efforts to promote the interests of the Company. Following an annual or special
meeting of the Company's stockholders at which stockholders approve the
Incentive Plan, Ms. Weisberg will receive options with a value of $5,000 on the
first trading day of each calendar month. Each month's options will have an
exercise price equal to the fair market value of the common stock on the last
trading day of the previous calendar month. All options granted on the first
trading day of each calendar month shall vest immediately and the options will
be issued quarterly in accordance with the terms of the Incentive Plan.
Pursuant to the Weisberg Director Agreement, Ms. Weisberg shall be considered an
independent contractor and shall be reimbursed for (i) all reasonable
out-of-pocket expenses incurred by her in attending in-person meetings and (ii)
any costs associated with filing required to be made by her or any of the
entities managed or controlled by her to report beneficial ownership or the
acquisition of disposition of securities of the Company. Ms. Weisberg's term,
subject to nomination and election at each of the Company's annual stockholders
meeting, will terminate at the earliest of her resignation, death, termination
by mutual agreement of the Company and herself, or the removal of Ms. Weisberg
by the majority of the stockholders of the Company.
The foregoing description of the Weisberg Director Agreement does not purport to
be complete and is qualified in its entirety by the full text of the Weisberg
Director Agreement which is filed as Exhibit 10.2 hereto and is incorporated
herein by reference.
Related Party Transactions
There is no arrangement or understanding between Ms. Weisberg and any other
person pursuant to which Ms. Weisberg was elected as a director. There are no
family relationships between Ms. Weisberg and any director, executive officer or
person nominated or chosen by the Company to become a director or executive
officer of the Company within the meaning of Item 401(d) of Regulation S-K under
the U.S. Securities Act of 1933 ("Regulation S-K"). Since the beginning of the
Company's last fiscal year, the Company has not engaged in any transaction in
which Ms. Weisberg had a direct or indirect material interest within the meaning
of Item 404(a) of Regulation S-K.
Appointment of Richard Schurfeld
The Company and Mr. Schurfeld entered into a Director Agreement, dated December
19, 2022 (the "Schurfeld Director Agreement"). The terms of the Schurfeld
Director Agreement are substantially the same as the terms of the Weisberg
Director Agreement.
Related Party Transactions
There is no arrangement or understanding between Mr. Schurfeld and any other
person pursuant to which Mr. Schurfeld was elected as a director. There are no
family relationships between Mr. Schurfeld and any director, executive officer
or person nominated or chosen by the Company to become a director or executive
officer of the Company within the meaning of Item 401(d) of Regulation S-K under
the U.S. Securities Act of 1933 ("Regulation S-K"). Since the beginning of the
Company's last fiscal year, the Company has not engaged in any transaction in
which Mr. Schurfeld had a direct or indirect material interest within the
meaning of Item 404(a) of Regulation S-K.
Indemnification Agreements
On December 19, 2022, the Company entered into an Indemnification Agreement with
each of Ms. Weisberg and Mr. Schurfeld (the "Indemnification Agreements").
The Indemnification Agreements indemnifies to the fullest extent permitted under
Nevada law for any claims arising out of or resulting from, amongst other
things, (i) any actual, alleged or suspected act or failure to act by Ms.
Weisberg and Mr. Schurfeld (together, the "Indemnitees") in their capacity as a
director or agent of the Company and (ii) any actual, alleged or suspected act
or failure to act by the Indemnitees in respect of any business, transaction,
communication, filing, disclosure or other activity of the Company. Under the
Indemnification Agreements, the Indemnitees are indemnified for any losses
pertaining to such claims, provided, however, that the losses shall not include
expenses incurred by the Indemnitees in respect of any claim as which they shall
have been adjudged liable to the Company, unless the court having jurisdiction
rules otherwise.
The foregoing description of the Indemnification Agreements do not purport to be
complete and is qualified in its entirety by the full text of the
Indemnification Agreement a form of which is filed as Exhibit 10.3 and is
incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
10.1 Consulting Agreement, by and between the Company and Jay Jones,
dated December 19, 2022
10.2 Weisberg Director Agreement, by and between the Company and Ms.
Weisberg, dated December 19, 2022
10.3 Form of Indemnification Agreement
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses